For the year ending 2025-12-31, BTSG had $27,224K increase in cash & cash equivalents over the period. $394,685K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) | 189,113 |
| Depreciation and amortization | 164,277 |
| Impairment of long-lived assets | 12,628 |
| Change in fair value of contingent consideration, net | -1,266 |
| Payment of contingent consideration in excess of acquisition date fair value | 6,170 |
| Provision for credit losses | 56,227 |
| Amortization of deferred debt issuance costs | 11,242 |
| Share-based compensation | 70,099 |
| Deferred income taxes, net | 14,842 |
| Loss on disposition of fixed assets | -2,076 |
| Other | 4,356 |
| Accounts receivable | 131,287 |
| Prepaid expenses and other current assets | -30,669 |
| Inventories | 177,906 |
| Trade accounts payable | 264,171 |
| Accrued expenses | 32,003 |
| Other assets and liabilities | 36,193 |
| Net cash provided by operating activities | 490,169 |
| Purchases of property and equipment | 95,484 |
| Acquisitions of businesses, net of cash acquired | 204,564 |
| Other | 5,031 |
| Net cash used in investing activities | -305,079 |
| Long-term debt repayments | 50,275 |
| (repayments) borrowings of the revolving credit facility, net | -63,300 |
| Repurchase of shares of common stock | 43,173 |
| Proceeds from shares issued under share-based compensation plan | 25,281 |
| Payment of taxes related to net share settlement of equity awards | 7,554 |
| Payment of contingent consideration up to acquisition date fair value | 200 |
| Purchase of redeemable noncontrolling interest | 5,100 |
| Payment of financing lease obligations | 13,545 |
| Net cash (used in) provided by financing activities | -157,866 |
| Net increase (decrease) in cash and cash equivalents | 27,224 |
| Cash and cash equivalents at beginning of year | 61,253 |
| Cash and cash equivalents at end of year | 88,477 |
BrightSpring Health Services, Inc. (BTSG)
BrightSpring Health Services, Inc. (BTSG)